Appili Therapeutics Inc. (APLI.TO)

CAD 0.04

(-12.5%)

Operating Expenses Summary of Appili Therapeutics Inc.

Appili Therapeutics Inc.'s latest annual operating expenses in 2023 was 8.83 Million CAD , up 8.96% from previous year.
Appili Therapeutics Inc.'s latest quarterly operating expenses in 2024 Q1 was 2.78 Million CAD , down -87.75% from previous quarter.
Appili Therapeutics Inc. reported a annual operating expenses of 8.1 Million CAD in annual operating expenses 2022, down -67.49% from previous year.
Appili Therapeutics Inc. reported a annual operating expenses of 24.94 Million CAD in annual operating expenses 2021, up 53.24% from previous year.
Appili Therapeutics Inc. reported a quarterly operating expenses of 2.42 Million CAD for 2023 Q4, up 637.34% from previous quarter.
Appili Therapeutics Inc. reported a quarterly operating expenses of 8.83 Million CAD for 2023 FY, up 8.96% from previous quarter.

Annual Operating Expenses Chart of Appili Therapeutics Inc. (2023 - 2016)

Historical Annual Operating Expenses of Appili Therapeutics Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	8.83 Million CAD	8.96%
2022	8.1 Million CAD	-67.49%
2021	24.94 Million CAD	53.24%
2020	16.28 Million CAD	190.55%
2019	5.6 Million CAD	-21.57%
2018	7.14 Million CAD	89.63%
2017	3.76 Million CAD	0.23%
2016	3.75 Million CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	2.78 Million CAD	-87.75%
2023 Q4	2.42 Million CAD	637.34%
2023 FY	8.83 Million CAD	8.96%
2023 Q3	328.9 Thousand CAD	-56.46%
2023 Q2	755.34 Thousand CAD	-42.27%
2023 Q1	1.3 Million CAD	-48.7%
2022 Q1	2 Million CAD	-8.21%
2022 Q4	2.55 Million CAD	7.32%
2022 FY	8.1 Million CAD	-67.49%
2022 Q3	2.37 Million CAD	102.41%
2022 Q2	1.17 Million CAD	-41.54%
2021 Q3	4.38 Million CAD	-60.33%
2021 FY	24.94 Million CAD	53.24%
2021 Q1	7.33 Million CAD	47.74%
2021 Q2	11.05 Million CAD	50.57%
2021 Q4	2.18 Million CAD	-50.09%
2020 FY	16.28 Million CAD	190.55%
2020 Q1	2.59 Million CAD	106.36%
2020 Q4	4.96 Million CAD	16.32%
2020 Q3	4.27 Million CAD	70.01%
2020 Q2	2.51 Million CAD	-3.34%
2019 Q3	1.34 Million CAD	20.88%
2019 Q2	1.11 Million CAD	-41.01%
2019 Q1	1.88 Million CAD	51.85%
2019 FY	5.6 Million CAD	-21.57%
2019 Q4	1.25 Million CAD	-6.36%
2018 FY	7.14 Million CAD	89.63%
2018 Q4	1.24 Million CAD	7.97%
2018 Q1	680.26 Thousand CAD	-43.93%
2018 Q2	1.29 Million CAD	91.02%
2018 Q3	1.15 Million CAD	-11.46%
2017 FY	3.76 Million CAD	0.23%
2017 Q4	1.21 Million CAD	18.34%
2017 Q3	1.02 Million CAD	0.0%
2016 FY	3.75 Million CAD	0.0%

Peer Operating Expenses Comparison of Appili Therapeutics Inc.

Name	Operating Expenses	Operating Expenses Difference
Eupraxia Pharmaceuticals Inc.	37.92 Million CAD	76.698%
Helix BioPharma Corp.	9.35 Million CAD	5.558%
Microbix Biosystems Inc.	10.21 Million CAD	13.514%
Medicenna Therapeutics Corp.	19.66 Million CAD	55.058%
Satellos Bioscience Inc.	6.64 Million CAD	-32.966%
Oncolytics Biotech Inc.	33.79 Million CAD	73.848%
Sernova Corp.	41.13 Million CAD	78.515%